Grace Therapeutics (GRCE)
Grace Therapeutics (GRCE) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- GRCE last traded at $1.73 on 2026-11-19, 0.00% for the session.
- Grace Therapeutics: market cap $36.39M, next earnings 2027-02-15.
- Over the past year GRCE returned -44.55%, with a year-to-date return of -50.00%.